As of May 27
| +0.85 / +0.70%|
The 7 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 147.00, with a high estimate of 150.00 and a low estimate of 104.00. The median estimate represents a +19.70% increase from the last price of 122.81.
The current consensus among 7 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.